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Cyproheptadine hydrochloride (CPH), methdilazine hydrochloride (MDH) and promethazine theo-
clate (PMT) were determined in their pure state and in pharmaceutical formulations by a simple spec-
trophotometric method. The determination was based on the formation of a charge-transfer complex
between chloranilic acid as a -acceptor and the studied drugs as n-donors in an acetonitrile-chloroform
mixture. The spectra, various experimental parameters, the stoichiometry and the stability of the com-
plexes formed were investigated. The complexes formed were found to absorb at 520 nm. Beer’s law is
obeyed in the concentration ranges 25-125, 20-100 and 25-150 g ml−1, for CPH, MDH and PMT re-
spectively. The corresponding values of molar absorptivity and Sandell sensitivity are 1.48 x 103, 1.56 x
103 and 1.75 x 103 1 mol−1 cm−1 and 217.39, 212.44 and 284.63 ng cm−2, respectively. The applicability
of the method was demonstrated by the determination of the studied drugs in commercial tablets and
syrup, and the results were statistically evaluated.
Introduction
The three antihistaminic drugs investigated are of diverse chemical types, and many chemical methods have
been reported for their assay.
Cyproheptadine hydrochloride (CPH) is a serotonin and a histamine antagonist with anticholinergic
and sedative eects. It also blocks voltage sensitive calcium channels in pancreatic islet cells and smooth
muscle. CPH is also used as an appetite stimulant to assist weight gain. The majority of methods found
in the literature for the determination of cyproheptadine were devoted to biological materials. Methods for
the assay of the drug in pharmaceutical preparations are few and include uv-spectrophotometry1 , visible
spectrophotometry 2−4, ion-selective electrode based potentiometry5;6, gas chromatography7;8 and high
performance liquid chromatography9−11, though the last two techniques are not always widely available.
Methdilazine hydrochloride (MDH) belongs to the phenothiazine class of drugs. Medicinally, it has
been used as an antihistamine and it is also found to possess antipruritic action. Several spectrophotometric
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methods based on such diverse reactions as oxidative coupling12;13, complex formation14, condensation15,
ion-association complex formation16 and radical cation formation using sodium cobaltinitrite17 and iodic
acid18 have been reported for the determination of MDH in tablets and syrup.
Promethazine theoclate (PMT) is an antihistamine/H1 receptor antagonist. It is also a phenothiazine
derivative which has very little dopaminergic action. It is primarily an antihistamine with additional sedative
and antiemetic actions. PMT is used in the treatment of nausea and vomiting associated with migraine
labyrinthine disorders and radiation therapy. Literature on the methods reported for the assay of PMT is
scarce. Davidson19 determined the drug in pharmaceutical formulations by a dierential spectrophotometric
method. A condensation reaction involving PMT and formaldehyde in strong sulphuric acid at 4-5 C
and subsequent measurement of the coloured product at 551 nm was reported20 . Recently, a flow-injection
method with cerium (IV) oxidation of the drug and measurement of the coloured radical cation was described
by Martinez and Garcia21.
Charge-transfer complexes result from a donor-acceptor mechanism of a Lewis acid base reaction
between two or more dierent chemical constituents. The formation of electron donor-acceptor complexes
can be rapidly assessed for their validity as a simple quantitative analytical method for many drug substances
which can act as electron donors. Chloranilic acid (CAA) as a -acceptor has been successfully utilized for
the spectrophotometric determination of a variety of electron donating basic compounds including some
antimalarials22, tranquilizers23, diethylcarbamazine citrate24 and ketomine hydrochloride25. In the work
described in this paper, the reagent was utilized to develop a simple, precise and accurate method for the
spectrophotometric determination of three antihistamines, CPH, MDH and PMT, either in their pure form
or in tablet and syrup preparations.
Experimental
Apparatus
A Systronics model 106 digital spectrophotometer (AHMEDABAD, INDIA) with 1 cm glass cells were used
for absorbance measurements.
Reagents
Pharmaceutical grade CPH, (Cipla Inida, Ltd.), MDH (Glaxo Allenburgs Ltd.) and PMT (Rhone Poulenc,
India) were used as working standards. CAA (s.d. Fine. Chem. India, Ltd.) solution, 0.1%, was freshly
prepared in acetonitrile. All other reagents and solvents used were of analytical grade.
Standard solutions
An accurately weighed amount of drug salt CPH, MDH or PMT equivalent to 100 mg of the base was
dissolved in about 20 ml distilled water. The solution was quantitatively transferred into a separating funnel,
made alkaline with ammonia solution and shaken with ve 20 ml portions of chloroform. The extracts were
pooled by ltration through a lter paper containing anhydrous sodium sulphate into a 100 ml standard
flask and made up to volume with chloroform to provide a stock standard 1 mg ml−1 solution of the base.
This was diluted to get a working concentration of 500 g ml−1.
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Procedures
Calibration graphs
Serial volumes of standard solutions ranging from 0.25 to 1.25 ml (CPH), 0.20 to 1.00 ml (MDH) or 0.25
to 1.50 ml (PMT) were transferred to 5 ml standard flasks and the volume was brought to 2 ml by adding
requisite volumes of chloroform. Then, 0.50 ml of 0.1% CAA reagent was added and the volume was
brought to 5 ml with acetonitrile and the absorbance was measured at 520 nm against a reagent blank
prepared simultaneously. The calibration graph in each instance was prepared by plotting the measured
absorbance versus drug concentration. The concentration of the unknown was read from the calibration
graph or computed from the regression equation.
Analysis of tablets
Twenty tablets were nely powdered and mixed. An accurately weighed quantity equivalent to the drug base
concentration mentioned in the standard solution preparation was transferred to a 100 ml standard flask
and extracted with 60 ml of distilled water by vigorous shaking for 20 min. For avomine tablets (PMT),
2 ml of 0.1 M HCl was used to aid the dissolution of the salt. The solution was then made up to volume
with water, mixed and ltered. In a separating funnel, a 50 ml portion of the ltrate was made alkaline to
litmus paper with ammonia solution and extracted with four successive 10 ml portions of chloroform, which
were pooled, dried over anhydrous sodium sulphate, and diluted accurately to 50 ml with chloroform as the
standard solution. This was further diluted to obtain the working solutions with chloroform. A suitable
aliquot was treated as described under the preparation of calibration graphs.
Analysis of syrup
An accurately measured volume of the mixed dilosyn syrup (MDH) equivalent to 50 mg of drug base was
quantitatively transferred into a separating funnel and treated as described for tablets except that nal
volume was 50 ml. After diluting this 1 mg ml−1 solution suitably, an appropriate volume was subjected to
analysis.
Results and Discussion
Chloranilic acid (CAA) solution in acetonitrile gives an absorption spectrum with an absorption maximum
at 430 nm. On addition of chloroformic solution of CPH, MDH or PMT to CAA solution, a bathochromic
shift to a longer wavelength is obtained at room temperature (Figure 2). This new absorption band formed
is the result of the formation of charge-transfer complex through the interaction of CAA as a -acceptor and
the studied drugs as n-donors followed by the formation of radical anion according to the following scheme26 :
D + CAA
(Donor) (Acceptor)
[D               CAA]
n – pi complex
D.+ + CAA.–
Radical ions
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The formation of a radical anion in such molecular interactions has been established by electron-spin
resonance measurements27−29.
Optimization of experimental variables
The influence of various factors on the colour development was studied to determine the optimal conditions,
such as reagent concentration and choice of solvent. CAA solution in various solvents failed to give
quantitative results. However, CAA in acetonitrile readily reacted stoichiometrically with all the three
antihistamines investigated forming a single purple chloranilic acid radical anion. Acetonitrile proved to be
most suitable diluting solvent as it gives good solvating capacity for CAA, and gives the highest yield of
the radical anion. Solvents such as chloroform, 2-propanol, dichloroethane, 1,4 { dioxane were not suitable,
because the complex formed in these solvents either had low absorbance or was precipitated on dilution.
The reaction between the drugs and CAA in acetonitrile was instantaneous and the product remained stable
for at least 24 h.
Maximum absorbance was obtained when 0.5 ml of 0.1% CAA solution was used in a total volume
of 5 ml. Figure 3 shows the relationship between the absorbance and concentration of chloranilic acid at a
xed drug concentration.
N
N
S
N
N
S
CH2
CH3
. HCl
CH2 CH N
C H 3
C H 3
CH3
CH3
CPH MDH
PMT
Figure 1. Structures of the antihistamines studied
Molecular ratio and formation constant
The stoichiometry of the reaction between CAA and CPH, MDH or PMT was studied by Job’s method of
continuous variations30. The plot (Figure 4) indicates that the interaction occurs through the formation
of 1:1 (donor: acceptor) complex in all three cases. This is in agreement with the presence of a single
tertiary nitrogen atom in CPH, MDH or PMT molecule (Figure 1). The formation constant (K) and molar
absorptivity (2) of the drug { CAA complex were determined by using the Benesi-Hildebrand equation31:
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Figure 2. Absorption spectra of the CT complex formed
between the drugs and CAA. 1. CPH (100g ml−1)
2. PMT (125 g ml−1) 3. MDH (80 g ml−1) 4. Blank
Figure 3. Eect of CAA concentration on complex
formation 1. CPH (100 g ml−1) 2. PMT (100 g ml−1)
3. MDH (60 g ml−1)
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Figure 5. Benesi-Hildebrand plots of CT complexes
of CPH, MDH and PMT with CAA, 1 PMT, 2 CPH,
3. MDH
[A0]
A
=
1
K
[D0] 2 + 12
where K is the formation constant, A is the absorbance and 2 is the molar extinction coecient of the
complex, and [A0] and [D0] are the initial concentrations of the acceptor and donor, respectively. Formation
constants were obtained from the ratio of intercept to slope and 2 from the inverse intercept of Benesi-
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Hildebrand plots (Figure 5), which were prepared by keeping the concentration of CAA constant, and lower
than the varied concentrations of the drugs as described in the procedures. The results of the study are
presented in Table 1.
Table 1. Analytical parameters for the charge-transfer complexes of CPH, MDH and PMT with CAA.
Parameter CPH MDH PMT
Beer’s law limits, g ml−1 25-125 20-100 25-150
Limit of detection, g ml−1 1.07 0.96 1.43
Limit of quantication, g ml−1 3.57 3.21 4.76
Molar absorptivity, l mol−1cm−1
1.48 x 103 a 1.56 x 103 a 1.75 x 103 a
1.42 x 103b 1.53 x 103 b 1.81 x 103b
Sandell sensitivity ng cm−2 per 0.001 217.39 212.44 284.63
absorbance unit
Regression equation*
Intercept, a 0.0284 0.001 0.0296
Slope, b 0.0041 0.0046 0.0031
Condence interval of intercept, 0.0284  0.0776 0.001  0.9506 0.0296  0.0672
Condence interval of slope,  0.0041  0.0009 0.0046  0.0143 0.0031  0.0006
Correlation coecient, r 0.9976 0.9990 0.9997
Formation constant, K.
1.02 x 103 b 1.16 x 103 b 0.68 x 103b
1.21 x 103 c 1.23 x 103 c 0.80 x 103 c
 Y = a + bX where Y is the absorbance for concentration, X in g ml−1.
a : from Beer’s law data.
b : from Benesi-Hildebrand plot.
c : from Turner and Anderson plot.
Analytical data
Beer’s law limits, detection limits, molar absorptivity and Sandell sensitivity values are given in Table 1.
Regression analysis indicated that the values of the intercept are small; the values were 0.0284, 0.0010 and
0.0296 for CPH, MDH and PMT respectively. Correlation coecient values range from 0.9976 to 0.9997,
suggesting a perfect linearity between the absorbance and concentration of drugs in the Beer’s law limits
studied.
Accuracy and precision
The accuracy of the method was established by performing seven replicate analyses on solutions containing
four dierent amounts (within the Beer’s law limits) of each drug and calculating the percentage error. The
precision was ascertained by calculating the relative standard deviation (RSD) for seven determinations at
each level. The range, percent error, standard deviation (SD), and RSD (%) are given in Table 2. The
comparision of the actual dierence between the mean and the true value (x - ) with the largest dierence
that could be expected as a result of indeterminate error ( ts / pn) is made in the last two columns of
Table 2. It is clear from the results that at all four levels (concentrations) studied, the values of (x - ) are
less than  ts / pn indicating that no signicant dierence exists between the mean and true values.
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Table 2. Evaluation of accuracy and precision of the method
Antihistamine Concentration Concentration Range, Error, S, RSD, % x−   ts
studied taken, found, g ml−1 % g ml−1 (n = 7)
p
n
g ml−1 g ml−1
50 49.32 2.35 1.36 0.96 1.96 0.68 0.86
CPH 75 74.46 1.81 0.72 0.68 0.92 0.54 0.61
100 99.89 0.50 0.11 0.45 0.46 0.11 0.41
20 20.14 0.69 0.70 0.34 1.73 0.14 0.22
MDH 60 60.32 0.89 0.53 0.44 0.74 0.32 0.39
100 100.35 1.66 0.35 0.57 0.57 0.35 0.51
50 50.08 1.71 0.16 0.77 1.53 0.08 0.68
PMT 75 75.40 1.04 0.53 0.55 0.73 0.40 0.49
100 100.79 2.81 0.79 0.95 0.94 0.79 0.85
 Mean value of seven determinations at each level
x = mean value;  = true value; t = 2.36 for n = 7 at 95% condence level.
S = standard deviation; RSD = relative standard deviation.
Application of the method to formulations
The method was applied successfully to the determination of CPH, MDH and PMT in their dosage forms.
The results presented in Table 3 reveal that the recoveries were in the range of 98.76-100.97%, reflecting the
high accuracy and precision of the method as indicated by low RSD values.
Table 3. Results of assay of CPH, MDH and PMT in their dosage forms
Label
Drug Dosage form claim, Found, Mean recovery, % RSD, %
and brand name mg/tablet $ mg (n = 7) (n = 7)
CPH Ciplactin tabletsa 4.00 3.98 99.54 1.04
Ciplactin syrupa 2 mg/5ml 2.01 100.97 0.37
Practin tabletsb 4.00 3.96 99.16 2.21
Practin syrupb 2 mg/5 ml 1.98 99.20 0.92
Peritol tabletsc 4.00 3.95 98.76 0.97
Peritol syrupc 2mg / 5ml 2.01 100.68 0.40
MDH Dilosyn tabletsd 8.00 8.10 101.25 1.13
Dilosyn syrupd 4 mg/ 5 ml 4.02 100.55 0.54
PMT Avomine tabletse 25.00 25.01 100.04 1.82
* Marketed by: a. Cipla; b. Merind; c. Themis Chemicals; d. Glaxo Allenburgs; e. Rhone-Poulenc.
$ Average of seven determinations.
Interferences
Excipients and llers added to formulations were tested for their interference in the procedure. Fortunately,
such auxillary substances as starch, talc, lactose, gelatin, magnesium stearate and sodium alginate exhibited
no interference, since in the proposed method the free base is extracted prior to the instant complexation
with CAA. This is clearly indicated from the results obtained for dosage forms (Table 3).
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Conclusions
The developed method is rapid, simple and fairly sensitive. It has the advantages of a wide range of
determination and high accuracy. The complex formed is stable for at least 24 h, thus permitting quantitative
analysis to be carried out with good reproducibility.
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